InChI=1S/C51H98O6/c1-4-7-10-13-16-19-22-24-25-27-29-32-35-38-41-44-50(53)56-47-48(46-55-49(52)43-40-37-34-31-28-21-18-15-12-9-6-3)57-51(54)45-42-39-36-33-30-26-23-20-17-14-11-8-5-2/h48H,4-47H2,1-3H3/t48-/m1/s1 |
JTDPHURHZMZJHD-QSCHNALKSA-N |
O(C(=O)CCCCCCCCCCCCCCC)[C@H](COC(CCCCCCCCCCCCC)=O)COC(=O)CCCCCCCCCCCCCCCCC |
|
human blood serum metabolite
Any metabolite (endogenous or exogenous) found in human blood serum samples.
|
|
View more via ChEBI Ontology
Outgoing
|
1-tetradecanoyl-2-hexadecanoyl-3-octadecanoyl-sn-glycerol
(CHEBI:108633)
has role
human blood serum metabolite
(CHEBI:85234)
1-tetradecanoyl-2-hexadecanoyl-3-octadecanoyl-sn-glycerol
(CHEBI:108633)
is a
triacyl-sn-glycerol
(CHEBI:64615)
1-tetradecanoyl-2-hexadecanoyl-3-octadecanoyl-sn-glycerol
(CHEBI:108633)
is a
triacylglycerol 48:0
(CHEBI:85870)
|
|
(2R)-2-(hexadecanoyloxy)-3-(tetradecanoyloxy)propyl octadecanoate
|
1-myristoyl-2-palmitoyl-3-stearoyl-sn-glycerol
|
ChEBI
|
TG(14:0/16:0/18:0)
|
ChEBI
|
TG(14:0/16:0/18:0)[iso6]
|
LIPID MAPS
|
24114462
|
PubMed citation
|
Europe PMC
|
|